Global Cough Remedies

Cough Remedies Comprehensive Study by Type (Antihistamines, Expectorants, Bronchodilators, Decongestants, Antibiotics, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Supermarkets/Hypermarkets, Online Pharmacies), Dosage Form (Oral Syrups, Tablets or Pills, Nasal Drops, Lozenges, Others) Players and Region - Global Market Outlook to 2026

Cough Remedies Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Cough Remedies Market Overview:
Cough is one of the commonest symptoms of respiratory tract infections and is a frequent problem faced in general practice as well as in hospital practice. A various disease processes may present with cough and definitive treatment depends on identifying the cause and diagnosis. Particular treatment of the cause should control the cough, but this may not happen in all cases and in a sizeable proportion of patients, no associated cause can be found. An augmented sensitivity of the cough reflex can be observed in patients with dry cough. The global cough remedies market is expected to witness a significant growth owing to increase in geriatric population and growth in awareness about advanced medicine.

Growth Drivers
  • Increase in Geriatric Population Across the Globe
  • Growth in Awareness About Advanced Medicine

Roadblocks
  • Strict Government Regulations

Opportunities
  • Development in R&D Activities Associated With Cough Remedies

Challenges
  • Side Effects Related to Cough Remedies


Competitive Landscape:

Some of the key players profiled in the report are Johnson & Johnson (United States), Reckitt Benckiser Group Plc (United Kingdom), Bayer Ag (Germany), Glaxosmithkline Plc. (United Kingdom), AstraZeneca (United Kingdom), Pfizer Inc. (United States), Sanofi (France), Novartis Ag (Switzerland), Prestige Brands, Inc. (United States) and Procter & Gamble (United States). Additionally, following companies can also be profiled that are part of our coverage like Merck & Co. (United States) and Sun Pharmaceutical Industries Ltd. (India). Analyst at AMA Research see United States and United Kingdom Players to retain maximum share of Global Cough Remedies market by 2026. Considering Market by Distribution Channel, the sub-segment i.e. Hospital Pharmacies will boost the Cough Remedies market. Considering Market by Dosage Form, the sub-segment i.e. Oral Syrups will boost the Cough Remedies market.

Latest Market Insights:
On February 21, 2019, Merck, known as MSD outside the United States and Canada, and Immune Design, today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Immune Design

The U.S. Food and Drug Administration (FDA) is requiring safety labeling changes for prescription cough and cold medicines containing codeine or hydrocodone to limit the use of these products to adults 18 years and older because the risks of these medicines outweigh their benefits in children younger than 18. FDA is also requiring the addition of safety information about the risks of misuse, abuse, addiction, overdose, death, and slowed or difficult breathing to the Boxed Warning, our most prominent warning, of the drug labels for prescription cough and cold medicines containing codeine or hydrocodone

What Can be Explored with the Cough Remedies Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Cough Remedies Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Cough Remedies
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Cough Remedies market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Cough Remedies market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Manufacturers of Cough Drugs, Suppliers of Cough Remedies, Distributers of Cough Remedies, Healthcare industry, Governmental bodies and Research Firms.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Antihistamines
  • Expectorants
  • Bronchodilators
  • Decongestants
  • Antibiotics
  • Others
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Supermarkets/Hypermarkets
  • Online Pharmacies

By Dosage Form
  • Oral Syrups
  • Tablets or Pills
  • Nasal Drops
  • Lozenges
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Switzerland
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in Geriatric Population Across the Globe
      • 3.2.2. Growth in Awareness About Advanced Medicine
    • 3.3. Market Challenges
      • 3.3.1. Side Effects Related to Cough Remedies
    • 3.4. Market Trends
      • 3.4.1. Increasing Demand of Over-The-Counter Products
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Cough Remedies, by Type, Distribution Channel, Dosage Form and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Cough Remedies (Value)
      • 5.2.1. Global Cough Remedies by: Type (Value)
        • 5.2.1.1. Antihistamines
        • 5.2.1.2. Expectorants
        • 5.2.1.3. Bronchodilators
        • 5.2.1.4. Decongestants
        • 5.2.1.5. Antibiotics
        • 5.2.1.6. Others
      • 5.2.2. Global Cough Remedies by: Distribution Channel (Value)
        • 5.2.2.1. Hospital Pharmacies
        • 5.2.2.2. Retail Pharmacies
        • 5.2.2.3. Drug Stores
        • 5.2.2.4. Supermarkets/Hypermarkets
        • 5.2.2.5. Online Pharmacies
      • 5.2.3. Global Cough Remedies by: Dosage Form (Value)
        • 5.2.3.1. Oral Syrups
        • 5.2.3.2. Tablets or Pills
        • 5.2.3.3. Nasal Drops
        • 5.2.3.4. Lozenges
        • 5.2.3.5. Others
      • 5.2.4. Global Cough Remedies Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Switzerland
          • 5.2.4.3.6. Netherlands
          • 5.2.4.3.7. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Cough Remedies (Price)
      • 5.3.1. Global Cough Remedies by: Type (Price)
  • 6. Cough Remedies: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Johnson & Johnson (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Reckitt Benckiser Group Plc (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Bayer Ag (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Glaxosmithkline Plc. (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. AstraZeneca (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Pfizer Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Sanofi (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Novartis Ag (Switzerland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Prestige Brands, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Procter & Gamble (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Cough Remedies Sale, by Type, Distribution Channel, Dosage Form and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Cough Remedies (Value)
      • 7.2.1. Global Cough Remedies by: Type (Value)
        • 7.2.1.1. Antihistamines
        • 7.2.1.2. Expectorants
        • 7.2.1.3. Bronchodilators
        • 7.2.1.4. Decongestants
        • 7.2.1.5. Antibiotics
        • 7.2.1.6. Others
      • 7.2.2. Global Cough Remedies by: Distribution Channel (Value)
        • 7.2.2.1. Hospital Pharmacies
        • 7.2.2.2. Retail Pharmacies
        • 7.2.2.3. Drug Stores
        • 7.2.2.4. Supermarkets/Hypermarkets
        • 7.2.2.5. Online Pharmacies
      • 7.2.3. Global Cough Remedies by: Dosage Form (Value)
        • 7.2.3.1. Oral Syrups
        • 7.2.3.2. Tablets or Pills
        • 7.2.3.3. Nasal Drops
        • 7.2.3.4. Lozenges
        • 7.2.3.5. Others
      • 7.2.4. Global Cough Remedies Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Switzerland
          • 7.2.4.3.6. Netherlands
          • 7.2.4.3.7. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Cough Remedies (Price)
      • 7.3.1. Global Cough Remedies by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Cough Remedies: by Type(USD Million)
  • Table 2. Cough Remedies Antihistamines , by Region USD Million (2015-2020)
  • Table 3. Cough Remedies Expectorants , by Region USD Million (2015-2020)
  • Table 4. Cough Remedies Bronchodilators , by Region USD Million (2015-2020)
  • Table 5. Cough Remedies Decongestants , by Region USD Million (2015-2020)
  • Table 6. Cough Remedies Antibiotics , by Region USD Million (2015-2020)
  • Table 7. Cough Remedies Others , by Region USD Million (2015-2020)
  • Table 8. Cough Remedies: by Distribution Channel(USD Million)
  • Table 9. Cough Remedies Hospital Pharmacies , by Region USD Million (2015-2020)
  • Table 10. Cough Remedies Retail Pharmacies , by Region USD Million (2015-2020)
  • Table 11. Cough Remedies Drug Stores , by Region USD Million (2015-2020)
  • Table 12. Cough Remedies Supermarkets/Hypermarkets , by Region USD Million (2015-2020)
  • Table 13. Cough Remedies Online Pharmacies , by Region USD Million (2015-2020)
  • Table 14. Cough Remedies: by Dosage Form(USD Million)
  • Table 15. Cough Remedies Oral Syrups , by Region USD Million (2015-2020)
  • Table 16. Cough Remedies Tablets or Pills , by Region USD Million (2015-2020)
  • Table 17. Cough Remedies Nasal Drops , by Region USD Million (2015-2020)
  • Table 18. Cough Remedies Lozenges , by Region USD Million (2015-2020)
  • Table 19. Cough Remedies Others , by Region USD Million (2015-2020)
  • Table 20. South America Cough Remedies, by Country USD Million (2015-2020)
  • Table 21. South America Cough Remedies, by Type USD Million (2015-2020)
  • Table 22. South America Cough Remedies, by Distribution Channel USD Million (2015-2020)
  • Table 23. South America Cough Remedies, by Dosage Form USD Million (2015-2020)
  • Table 24. Brazil Cough Remedies, by Type USD Million (2015-2020)
  • Table 25. Brazil Cough Remedies, by Distribution Channel USD Million (2015-2020)
  • Table 26. Brazil Cough Remedies, by Dosage Form USD Million (2015-2020)
  • Table 27. Argentina Cough Remedies, by Type USD Million (2015-2020)
  • Table 28. Argentina Cough Remedies, by Distribution Channel USD Million (2015-2020)
  • Table 29. Argentina Cough Remedies, by Dosage Form USD Million (2015-2020)
  • Table 30. Rest of South America Cough Remedies, by Type USD Million (2015-2020)
  • Table 31. Rest of South America Cough Remedies, by Distribution Channel USD Million (2015-2020)
  • Table 32. Rest of South America Cough Remedies, by Dosage Form USD Million (2015-2020)
  • Table 33. Asia Pacific Cough Remedies, by Country USD Million (2015-2020)
  • Table 34. Asia Pacific Cough Remedies, by Type USD Million (2015-2020)
  • Table 35. Asia Pacific Cough Remedies, by Distribution Channel USD Million (2015-2020)
  • Table 36. Asia Pacific Cough Remedies, by Dosage Form USD Million (2015-2020)
  • Table 37. China Cough Remedies, by Type USD Million (2015-2020)
  • Table 38. China Cough Remedies, by Distribution Channel USD Million (2015-2020)
  • Table 39. China Cough Remedies, by Dosage Form USD Million (2015-2020)
  • Table 40. Japan Cough Remedies, by Type USD Million (2015-2020)
  • Table 41. Japan Cough Remedies, by Distribution Channel USD Million (2015-2020)
  • Table 42. Japan Cough Remedies, by Dosage Form USD Million (2015-2020)
  • Table 43. India Cough Remedies, by Type USD Million (2015-2020)
  • Table 44. India Cough Remedies, by Distribution Channel USD Million (2015-2020)
  • Table 45. India Cough Remedies, by Dosage Form USD Million (2015-2020)
  • Table 46. South Korea Cough Remedies, by Type USD Million (2015-2020)
  • Table 47. South Korea Cough Remedies, by Distribution Channel USD Million (2015-2020)
  • Table 48. South Korea Cough Remedies, by Dosage Form USD Million (2015-2020)
  • Table 49. Taiwan Cough Remedies, by Type USD Million (2015-2020)
  • Table 50. Taiwan Cough Remedies, by Distribution Channel USD Million (2015-2020)
  • Table 51. Taiwan Cough Remedies, by Dosage Form USD Million (2015-2020)
  • Table 52. Australia Cough Remedies, by Type USD Million (2015-2020)
  • Table 53. Australia Cough Remedies, by Distribution Channel USD Million (2015-2020)
  • Table 54. Australia Cough Remedies, by Dosage Form USD Million (2015-2020)
  • Table 55. Rest of Asia-Pacific Cough Remedies, by Type USD Million (2015-2020)
  • Table 56. Rest of Asia-Pacific Cough Remedies, by Distribution Channel USD Million (2015-2020)
  • Table 57. Rest of Asia-Pacific Cough Remedies, by Dosage Form USD Million (2015-2020)
  • Table 58. Europe Cough Remedies, by Country USD Million (2015-2020)
  • Table 59. Europe Cough Remedies, by Type USD Million (2015-2020)
  • Table 60. Europe Cough Remedies, by Distribution Channel USD Million (2015-2020)
  • Table 61. Europe Cough Remedies, by Dosage Form USD Million (2015-2020)
  • Table 62. Germany Cough Remedies, by Type USD Million (2015-2020)
  • Table 63. Germany Cough Remedies, by Distribution Channel USD Million (2015-2020)
  • Table 64. Germany Cough Remedies, by Dosage Form USD Million (2015-2020)
  • Table 65. France Cough Remedies, by Type USD Million (2015-2020)
  • Table 66. France Cough Remedies, by Distribution Channel USD Million (2015-2020)
  • Table 67. France Cough Remedies, by Dosage Form USD Million (2015-2020)
  • Table 68. Italy Cough Remedies, by Type USD Million (2015-2020)
  • Table 69. Italy Cough Remedies, by Distribution Channel USD Million (2015-2020)
  • Table 70. Italy Cough Remedies, by Dosage Form USD Million (2015-2020)
  • Table 71. United Kingdom Cough Remedies, by Type USD Million (2015-2020)
  • Table 72. United Kingdom Cough Remedies, by Distribution Channel USD Million (2015-2020)
  • Table 73. United Kingdom Cough Remedies, by Dosage Form USD Million (2015-2020)
  • Table 74. Switzerland Cough Remedies, by Type USD Million (2015-2020)
  • Table 75. Switzerland Cough Remedies, by Distribution Channel USD Million (2015-2020)
  • Table 76. Switzerland Cough Remedies, by Dosage Form USD Million (2015-2020)
  • Table 77. Netherlands Cough Remedies, by Type USD Million (2015-2020)
  • Table 78. Netherlands Cough Remedies, by Distribution Channel USD Million (2015-2020)
  • Table 79. Netherlands Cough Remedies, by Dosage Form USD Million (2015-2020)
  • Table 80. Rest of Europe Cough Remedies, by Type USD Million (2015-2020)
  • Table 81. Rest of Europe Cough Remedies, by Distribution Channel USD Million (2015-2020)
  • Table 82. Rest of Europe Cough Remedies, by Dosage Form USD Million (2015-2020)
  • Table 83. MEA Cough Remedies, by Country USD Million (2015-2020)
  • Table 84. MEA Cough Remedies, by Type USD Million (2015-2020)
  • Table 85. MEA Cough Remedies, by Distribution Channel USD Million (2015-2020)
  • Table 86. MEA Cough Remedies, by Dosage Form USD Million (2015-2020)
  • Table 87. Middle East Cough Remedies, by Type USD Million (2015-2020)
  • Table 88. Middle East Cough Remedies, by Distribution Channel USD Million (2015-2020)
  • Table 89. Middle East Cough Remedies, by Dosage Form USD Million (2015-2020)
  • Table 90. Africa Cough Remedies, by Type USD Million (2015-2020)
  • Table 91. Africa Cough Remedies, by Distribution Channel USD Million (2015-2020)
  • Table 92. Africa Cough Remedies, by Dosage Form USD Million (2015-2020)
  • Table 93. North America Cough Remedies, by Country USD Million (2015-2020)
  • Table 94. North America Cough Remedies, by Type USD Million (2015-2020)
  • Table 95. North America Cough Remedies, by Distribution Channel USD Million (2015-2020)
  • Table 96. North America Cough Remedies, by Dosage Form USD Million (2015-2020)
  • Table 97. United States Cough Remedies, by Type USD Million (2015-2020)
  • Table 98. United States Cough Remedies, by Distribution Channel USD Million (2015-2020)
  • Table 99. United States Cough Remedies, by Dosage Form USD Million (2015-2020)
  • Table 100. Canada Cough Remedies, by Type USD Million (2015-2020)
  • Table 101. Canada Cough Remedies, by Distribution Channel USD Million (2015-2020)
  • Table 102. Canada Cough Remedies, by Dosage Form USD Million (2015-2020)
  • Table 103. Mexico Cough Remedies, by Type USD Million (2015-2020)
  • Table 104. Mexico Cough Remedies, by Distribution Channel USD Million (2015-2020)
  • Table 105. Mexico Cough Remedies, by Dosage Form USD Million (2015-2020)
  • Table 106. Cough Remedies: by Type(USD/Units)
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Company Basic Information, Sales Area and Its Competitors
  • Table 115. Company Basic Information, Sales Area and Its Competitors
  • Table 116. Company Basic Information, Sales Area and Its Competitors
  • Table 117. Cough Remedies: by Type(USD Million)
  • Table 118. Cough Remedies Antihistamines , by Region USD Million (2021-2026)
  • Table 119. Cough Remedies Expectorants , by Region USD Million (2021-2026)
  • Table 120. Cough Remedies Bronchodilators , by Region USD Million (2021-2026)
  • Table 121. Cough Remedies Decongestants , by Region USD Million (2021-2026)
  • Table 122. Cough Remedies Antibiotics , by Region USD Million (2021-2026)
  • Table 123. Cough Remedies Others , by Region USD Million (2021-2026)
  • Table 124. Cough Remedies: by Distribution Channel(USD Million)
  • Table 125. Cough Remedies Hospital Pharmacies , by Region USD Million (2021-2026)
  • Table 126. Cough Remedies Retail Pharmacies , by Region USD Million (2021-2026)
  • Table 127. Cough Remedies Drug Stores , by Region USD Million (2021-2026)
  • Table 128. Cough Remedies Supermarkets/Hypermarkets , by Region USD Million (2021-2026)
  • Table 129. Cough Remedies Online Pharmacies , by Region USD Million (2021-2026)
  • Table 130. Cough Remedies: by Dosage Form(USD Million)
  • Table 131. Cough Remedies Oral Syrups , by Region USD Million (2021-2026)
  • Table 132. Cough Remedies Tablets or Pills , by Region USD Million (2021-2026)
  • Table 133. Cough Remedies Nasal Drops , by Region USD Million (2021-2026)
  • Table 134. Cough Remedies Lozenges , by Region USD Million (2021-2026)
  • Table 135. Cough Remedies Others , by Region USD Million (2021-2026)
  • Table 136. South America Cough Remedies, by Country USD Million (2021-2026)
  • Table 137. South America Cough Remedies, by Type USD Million (2021-2026)
  • Table 138. South America Cough Remedies, by Distribution Channel USD Million (2021-2026)
  • Table 139. South America Cough Remedies, by Dosage Form USD Million (2021-2026)
  • Table 140. Brazil Cough Remedies, by Type USD Million (2021-2026)
  • Table 141. Brazil Cough Remedies, by Distribution Channel USD Million (2021-2026)
  • Table 142. Brazil Cough Remedies, by Dosage Form USD Million (2021-2026)
  • Table 143. Argentina Cough Remedies, by Type USD Million (2021-2026)
  • Table 144. Argentina Cough Remedies, by Distribution Channel USD Million (2021-2026)
  • Table 145. Argentina Cough Remedies, by Dosage Form USD Million (2021-2026)
  • Table 146. Rest of South America Cough Remedies, by Type USD Million (2021-2026)
  • Table 147. Rest of South America Cough Remedies, by Distribution Channel USD Million (2021-2026)
  • Table 148. Rest of South America Cough Remedies, by Dosage Form USD Million (2021-2026)
  • Table 149. Asia Pacific Cough Remedies, by Country USD Million (2021-2026)
  • Table 150. Asia Pacific Cough Remedies, by Type USD Million (2021-2026)
  • Table 151. Asia Pacific Cough Remedies, by Distribution Channel USD Million (2021-2026)
  • Table 152. Asia Pacific Cough Remedies, by Dosage Form USD Million (2021-2026)
  • Table 153. China Cough Remedies, by Type USD Million (2021-2026)
  • Table 154. China Cough Remedies, by Distribution Channel USD Million (2021-2026)
  • Table 155. China Cough Remedies, by Dosage Form USD Million (2021-2026)
  • Table 156. Japan Cough Remedies, by Type USD Million (2021-2026)
  • Table 157. Japan Cough Remedies, by Distribution Channel USD Million (2021-2026)
  • Table 158. Japan Cough Remedies, by Dosage Form USD Million (2021-2026)
  • Table 159. India Cough Remedies, by Type USD Million (2021-2026)
  • Table 160. India Cough Remedies, by Distribution Channel USD Million (2021-2026)
  • Table 161. India Cough Remedies, by Dosage Form USD Million (2021-2026)
  • Table 162. South Korea Cough Remedies, by Type USD Million (2021-2026)
  • Table 163. South Korea Cough Remedies, by Distribution Channel USD Million (2021-2026)
  • Table 164. South Korea Cough Remedies, by Dosage Form USD Million (2021-2026)
  • Table 165. Taiwan Cough Remedies, by Type USD Million (2021-2026)
  • Table 166. Taiwan Cough Remedies, by Distribution Channel USD Million (2021-2026)
  • Table 167. Taiwan Cough Remedies, by Dosage Form USD Million (2021-2026)
  • Table 168. Australia Cough Remedies, by Type USD Million (2021-2026)
  • Table 169. Australia Cough Remedies, by Distribution Channel USD Million (2021-2026)
  • Table 170. Australia Cough Remedies, by Dosage Form USD Million (2021-2026)
  • Table 171. Rest of Asia-Pacific Cough Remedies, by Type USD Million (2021-2026)
  • Table 172. Rest of Asia-Pacific Cough Remedies, by Distribution Channel USD Million (2021-2026)
  • Table 173. Rest of Asia-Pacific Cough Remedies, by Dosage Form USD Million (2021-2026)
  • Table 174. Europe Cough Remedies, by Country USD Million (2021-2026)
  • Table 175. Europe Cough Remedies, by Type USD Million (2021-2026)
  • Table 176. Europe Cough Remedies, by Distribution Channel USD Million (2021-2026)
  • Table 177. Europe Cough Remedies, by Dosage Form USD Million (2021-2026)
  • Table 178. Germany Cough Remedies, by Type USD Million (2021-2026)
  • Table 179. Germany Cough Remedies, by Distribution Channel USD Million (2021-2026)
  • Table 180. Germany Cough Remedies, by Dosage Form USD Million (2021-2026)
  • Table 181. France Cough Remedies, by Type USD Million (2021-2026)
  • Table 182. France Cough Remedies, by Distribution Channel USD Million (2021-2026)
  • Table 183. France Cough Remedies, by Dosage Form USD Million (2021-2026)
  • Table 184. Italy Cough Remedies, by Type USD Million (2021-2026)
  • Table 185. Italy Cough Remedies, by Distribution Channel USD Million (2021-2026)
  • Table 186. Italy Cough Remedies, by Dosage Form USD Million (2021-2026)
  • Table 187. United Kingdom Cough Remedies, by Type USD Million (2021-2026)
  • Table 188. United Kingdom Cough Remedies, by Distribution Channel USD Million (2021-2026)
  • Table 189. United Kingdom Cough Remedies, by Dosage Form USD Million (2021-2026)
  • Table 190. Switzerland Cough Remedies, by Type USD Million (2021-2026)
  • Table 191. Switzerland Cough Remedies, by Distribution Channel USD Million (2021-2026)
  • Table 192. Switzerland Cough Remedies, by Dosage Form USD Million (2021-2026)
  • Table 193. Netherlands Cough Remedies, by Type USD Million (2021-2026)
  • Table 194. Netherlands Cough Remedies, by Distribution Channel USD Million (2021-2026)
  • Table 195. Netherlands Cough Remedies, by Dosage Form USD Million (2021-2026)
  • Table 196. Rest of Europe Cough Remedies, by Type USD Million (2021-2026)
  • Table 197. Rest of Europe Cough Remedies, by Distribution Channel USD Million (2021-2026)
  • Table 198. Rest of Europe Cough Remedies, by Dosage Form USD Million (2021-2026)
  • Table 199. MEA Cough Remedies, by Country USD Million (2021-2026)
  • Table 200. MEA Cough Remedies, by Type USD Million (2021-2026)
  • Table 201. MEA Cough Remedies, by Distribution Channel USD Million (2021-2026)
  • Table 202. MEA Cough Remedies, by Dosage Form USD Million (2021-2026)
  • Table 203. Middle East Cough Remedies, by Type USD Million (2021-2026)
  • Table 204. Middle East Cough Remedies, by Distribution Channel USD Million (2021-2026)
  • Table 205. Middle East Cough Remedies, by Dosage Form USD Million (2021-2026)
  • Table 206. Africa Cough Remedies, by Type USD Million (2021-2026)
  • Table 207. Africa Cough Remedies, by Distribution Channel USD Million (2021-2026)
  • Table 208. Africa Cough Remedies, by Dosage Form USD Million (2021-2026)
  • Table 209. North America Cough Remedies, by Country USD Million (2021-2026)
  • Table 210. North America Cough Remedies, by Type USD Million (2021-2026)
  • Table 211. North America Cough Remedies, by Distribution Channel USD Million (2021-2026)
  • Table 212. North America Cough Remedies, by Dosage Form USD Million (2021-2026)
  • Table 213. United States Cough Remedies, by Type USD Million (2021-2026)
  • Table 214. United States Cough Remedies, by Distribution Channel USD Million (2021-2026)
  • Table 215. United States Cough Remedies, by Dosage Form USD Million (2021-2026)
  • Table 216. Canada Cough Remedies, by Type USD Million (2021-2026)
  • Table 217. Canada Cough Remedies, by Distribution Channel USD Million (2021-2026)
  • Table 218. Canada Cough Remedies, by Dosage Form USD Million (2021-2026)
  • Table 219. Mexico Cough Remedies, by Type USD Million (2021-2026)
  • Table 220. Mexico Cough Remedies, by Distribution Channel USD Million (2021-2026)
  • Table 221. Mexico Cough Remedies, by Dosage Form USD Million (2021-2026)
  • Table 222. Cough Remedies: by Type(USD/Units)
  • Table 223. Research Programs/Design for This Report
  • Table 224. Key Data Information from Secondary Sources
  • Table 225. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Cough Remedies: by Type USD Million (2015-2020)
  • Figure 5. Global Cough Remedies: by Distribution Channel USD Million (2015-2020)
  • Figure 6. Global Cough Remedies: by Dosage Form USD Million (2015-2020)
  • Figure 7. South America Cough Remedies Share (%), by Country
  • Figure 8. Asia Pacific Cough Remedies Share (%), by Country
  • Figure 9. Europe Cough Remedies Share (%), by Country
  • Figure 10. MEA Cough Remedies Share (%), by Country
  • Figure 11. North America Cough Remedies Share (%), by Country
  • Figure 12. Global Cough Remedies: by Type USD/Units (2015-2020)
  • Figure 13. Global Cough Remedies share by Players 2020 (%)
  • Figure 14. Global Cough Remedies share by Players (Top 3) 2020(%)
  • Figure 15. Global Cough Remedies share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 18. Johnson & Johnson (United States) Revenue: by Geography 2020
  • Figure 19. Reckitt Benckiser Group Plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 20. Reckitt Benckiser Group Plc (United Kingdom) Revenue: by Geography 2020
  • Figure 21. Bayer Ag (Germany) Revenue, Net Income and Gross profit
  • Figure 22. Bayer Ag (Germany) Revenue: by Geography 2020
  • Figure 23. Glaxosmithkline Plc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 24. Glaxosmithkline Plc. (United Kingdom) Revenue: by Geography 2020
  • Figure 25. AstraZeneca (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 26. AstraZeneca (United Kingdom) Revenue: by Geography 2020
  • Figure 27. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Pfizer Inc. (United States) Revenue: by Geography 2020
  • Figure 29. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 30. Sanofi (France) Revenue: by Geography 2020
  • Figure 31. Novartis Ag (Switzerland) Revenue, Net Income and Gross profit
  • Figure 32. Novartis Ag (Switzerland) Revenue: by Geography 2020
  • Figure 33. Prestige Brands, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Prestige Brands, Inc. (United States) Revenue: by Geography 2020
  • Figure 35. Procter & Gamble (United States) Revenue, Net Income and Gross profit
  • Figure 36. Procter & Gamble (United States) Revenue: by Geography 2020
  • Figure 37. Global Cough Remedies: by Type USD Million (2021-2026)
  • Figure 38. Global Cough Remedies: by Distribution Channel USD Million (2021-2026)
  • Figure 39. Global Cough Remedies: by Dosage Form USD Million (2021-2026)
  • Figure 40. South America Cough Remedies Share (%), by Country
  • Figure 41. Asia Pacific Cough Remedies Share (%), by Country
  • Figure 42. Europe Cough Remedies Share (%), by Country
  • Figure 43. MEA Cough Remedies Share (%), by Country
  • Figure 44. North America Cough Remedies Share (%), by Country
  • Figure 45. Global Cough Remedies: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Johnson & Johnson (United States)
  • Reckitt Benckiser Group Plc (United Kingdom)
  • Bayer Ag (Germany)
  • Glaxosmithkline Plc. (United Kingdom)
  • AstraZeneca (United Kingdom)
  • Pfizer Inc. (United States)
  • Sanofi (France)
  • Novartis Ag (Switzerland)
  • Prestige Brands, Inc. (United States)
  • Procter & Gamble (United States)
Additional players considered in the study are as follows:
Merck & Co. (United States) , Sun Pharmaceutical Industries Ltd. (India)
Select User Access Type

Key Highlights of Report


Sep 2021 209 Pages 67 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Cough Remedies Quantitative research analysis
Global Cough Remedies Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Cough Remedies market is expected to see a CAGR of % during projected year 2020 to 2026.
Top performing companies in the Global Cough Remedies market are Johnson & Johnson (United States), Reckitt Benckiser Group Plc (United Kingdom), Bayer Ag (Germany), Glaxosmithkline Plc. (United Kingdom), AstraZeneca (United Kingdom), Pfizer Inc. (United States), Sanofi (France), Novartis Ag (Switzerland), Prestige Brands, Inc. (United States) and Procter & Gamble (United States), to name a few.
"Increasing Demand of Over-The-Counter Products" is seen as one of major influencing trends for Cough Remedies Market during projected period 2020-2026.

Know More About Global Cough Remedies Report?

Have a Query? Click Here

Other Related Reports

Homeopathy Products Comprehensive Study by Type (Tincture, Dilutions, Ointments, Tablets, Others), Application (Analgesic & Antipyretic, Respiratory, Neurology, Immunology, Gastroenterology, Dermatol...
$ 3350
Vitamins Comprehensive Study by Type (Fat-soluble, Water-soluble), Application (Food & Beverages, Personal Care, Animal Feed, Pharmaceuticals), Distribution Channel (Hypermarket, Supermarket, Mass m...
$ 3450
Menopausal Hot Flashes Drug Comprehensive Study by Type (Capsule, Liniment, Tablet, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Treatment Type (Hormonal...
$ 3750
Smallpox Vaccine Comprehensive Study by Type (First Generation, Second Generation, Third Generation), Application (Vaccination) Players and Region - Global Market Outlook to 2026
$ 3500
Antifungal Drugs Comprehensive Study by Type (Gels, Cream, Shampoo, Injections, Liquids or Spray, Tablets (Pill)), Drugs (Azoles, Echinocandins, Polyenes, Others), Distribution Channel (Speciality cl...
$ 3750
Resveratrol Comprehensive Study by Type (Natural, Artificial), Application (Dietary supplements, Pharmaceutical, Personal care products, Others), Form (Solid, Liquid) Players and Region - Global Mark...
$ 3500